Remove 2012 Remove Medical Remove Therapy
article thumbnail

Study: The Number of New Dermatology Drugs Approved by the FDA Is on the Rise

The Dermatology Digest

Food and Drug Administration (FDA) increased between 2012 and 2022 compared with prior decades, according to a research letter in JAMA Dermatology. Prior studies found few markers of innovation, such as priority review or orphan designation, among topical medications approved from 2000 to 2014.”

article thumbnail

Malignant Melanoma

First Derm

Malignant Melanoma Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell Common More than 200,000 US cases per year Requires medical diagnosis Symptoms: Abnormal growth in moles Color: Typically brown Location: Anywhere on the skin Treatment: Surgery, Chemotherapy Death Rate Incident Rate ICD-10: C43.9

Surgery 98
article thumbnail

Median Nail Dystrophy

First Derm

Median Nail Dystrophy Medically reviewed by Dennis A Porto, MD and The Dermatologists Median Nail Dystrophy (01) finger nail [ICD-10 L60.3] Another factor that has been reported to cause median nail dystrophy is medication, such as oral isotretinoin. Should I seek medical care? ICD-9: 703.8 Dystrophies of the nail.

article thumbnail

Ozempic vs Berberine: What's the Difference?

Aesthetics Advisor

Ozempic and Wegovy are prescription medications that are said to directly target gut hormones involved in appetite and blood sugar. History of Ozempic 2012: Semaglutide, the active ingredient in both Wegovy and Ozempic, was developed by Novo Nordisk. Here are their differences, research highlights, and how they work.

article thumbnail

Acid Reflux May Respond Better to Foods Than Prescribed Pills

Aesthetics Advisor

Americans spend a whopping $13 billion a year on over-the-counter and prescription proton pump inhibitors (PPIs), which are the most popular anti-reflux medications on the market. Authors of a 2012 study indicating the beneficial effects of alkaline water on reflux disease noted: 9 "Unlike conventional drinking water, pH 8.8

Diet 36
article thumbnail

Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades

The Dermatology Digest

“There has been a substantial increase in the use of systemic and biologic therapies over time, which is an important step in bridging the treatment gap for moderate-to-severe pediatric psoriasis patients,” noted Carmel Aghdasi, BA, one of the study authors.

article thumbnail

Pediatric Psoriasis: Characteristics of a Cohort at UCSF Spanning 2 Decades

The Dermatology Digest

“There has been a substantial increase in the use of systemic and biologic therapies over time, which is an important step in bridging the treatment gap for moderate-to-severe pediatric psoriasis patients,” noted Carmel Aghdasi, BA, one of the study authors.